OHSU case study looks at seven cases of acute myocarditis in healthy male teens within four days of their second of Pfizer-BioNTech.

A study led by Ahmed Raslan, M.D., finds people of color are more than twice as likely to die after a traumatic brain injury as white people: "We have a societal and professional duty to recognize and accept that the effects of structural racism have taken hold of our patients' health long before they arrive in our trauma bays, ICU beds, and operating tables."

Maria Rodriguez, M.D., publishes column on women's access to abortion care in Oregon.

A column authored by St. Alphonsus Cancer Institute oncologist highlights findings of a community needs assessment conducted in partnership with OHSU Knight Cancer Institute

An OHSU study led by Jonah Sacha, Ph.D., finds an experimental, lab-made antibody can completely prevent nonhuman primates from being infected with the monkey form of HIV: “Our study findings indicate leronlimab could be a new weapon against the HIV epidemic."

An OHSU study led by Andrew McHill, Ph.D., on how travel impacted NBA players' performance when the bubble emerged last year is cited in a story on why the Lakers were eliminated from the playoffs.

Profile of a patient who benefited from treatment received at OHSU's Long COVID-19 Program.

An international study led at OHSU by Tomasz Beer, M.D., establishes a new therapy for men with prostate cancer that has spread and become resistant to hormone therapy: "This is a completely new treatment option that extends life and disease control in metastatic castration-resistant prostate cancer –- the most aggressive and deadly type."

The Northwest Portland Area Indian Health Board and OHSU's Northwest Native American Center of Excellence produce and release a public service announcement recognizing the efforts of Northwest tribal communities, who are being vaccinated at a higher rate than other ethnic populations.

Michael Recht, M.D., Ph.D., presents clinical data showing clinical benefit in hemophilia B patients in avnew gene therapy trial.